Cyclo-oxygenase-1 or -2-mediated metabolism of arachidonic acid in endothelium-dependent contraction of mouse arteries

Experimental Physiology

Volumn 98, Issue 7, 2013, Pages 1225-1234

  Zhou, Yingbi ^a   Luo, Wenhong ^a   Zhang, Yingzhan ^a   Li, Hui ^a   Huang, Dongyang ^a   Liu, Bin ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; PROSTACYCLIN; PROSTAGLANDIN H2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BLOOD VESSEL REACTIVITY; CAROTID ARTERY; ENDOTHELIUM; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; VASOMOTOR REFLEX;

EID: 84879462616     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2013.072017     Document Type: Article

References (43)

1. 3 adenosine receptor-mediated contraction through endothelium in mice aorta. Am J Physiol Heart Circ Physiol 293, H3448-H3455.
2. Bolego C, Buccellati C, Prada A, Gaion RM, Folco G & Sala A (2009). Critical role of COX-1 in prostacyclin production by human endothelial cells under modification of hydroperoxide tone. FASEB J 23, 605-612.
3. Brueggemann LI, Mackie AR, Mani BK, Cribbs LL & Byron KL (2009). Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles. Mol Pharmacol 76, 1053-1061.
4. Bunting S, Gryglewski R, Moncada S & Vane JR (1976). Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins 12, 897-913.
5. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA & FitzGerald GA (2002). Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296, 539-541.
6. Davidge ST (2001). Prostaglandin H synthase and vascular function. Circ Res 89, 650-660.
7. FitzGerald GA, Cheng Y & Austin S (2001). COX-2 inhibitors and the cardiovascular system. Clin Exp Rheumatol 19, S31-S36.
8. Fulton CT & Stallone JN (2002). Sexual dimorphism in prostanoid-potentiated vascular contraction: roles of endothelium and ovarian steroids. Am J Physiol Heart Circ Physiol 283, H2062-H2073.
9. Gauthier KM, Goldman DH, Aggarwal NT, Chawengsub Y, Falck JR & Campbell WB (2011). Role of arachidonic acid lipoxygenase metabolites in acetylcholine relaxations of mouse arteries. Am J Physiol Heart Circ Physiol 300, H725-H735.
10. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM & Feletou M (2005). Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 146, 834-845.
11. Grosser T, Fries S & FitzGerald GA (2006). Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest 116, 4-15.
12. 2 biosynthesis. J Biol Chem 264, 141-150.
13. Ihara E, Hirano K, Derkach DN, Nishimura J, Nawata H & Kanaide H (2000). The mechanism of bradykinin-induced endothelium-dependent contraction and relaxation in the porcine interlobar renal artery. Br J Pharmacol 129, 943-952.
14. Ihara E, Hirano K, Nishimura J, Nawata H & Kanaide H (1999). Thapsigargin-induced endothelium-dependent triphasic regulation of vascular tone in the porcine renal artery. Br J Pharmacol 128, 689-699.
15. Imig JD (2006). Eicosanoids and renal vascular function in diseases. Clin Sci (Lond) 111, 21-34.
16. Katusić ZS & Shepherd JT (1991). Endothelium-derived vasoactive factors: II. Endothelium-dependent contraction. Hypertension 18, III86-III92.
17. Kirkby N, Lundberg M, Harrington L, Leadbeater P, Milne G, Potter C, Al-Yamani M, Adeyemi O, Warner T & Mitchell J (2012). Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system. Proc Natl Acad Sci U S A 109, 17597-17602.
18. Klein T, Eltze M, Grebe T, Hatzelmann A & Komhoff M (2007). Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition. Cardiovasc Res 75, 390-397.
19. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS & Smithies O (1995). Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83, 483-492.
20. Levy JV (1978). Contractile responses to prostacyclin (PGI2) of isolated human saphenous and rat venous tissue. Prostaglandins 16, 93-97.
21. Liu B, Luo W, Zhang Y, Li H, Zhang J, Tan XR & Zhou Y (2012a). Concomitant activation of functionally opposing prostacyclin and thromboxane prostanoid receptors by cyclo-oxygenase-1-mediated prostacyclin synthesis in mouse arteries. Exp Physiol 97, 895-904.
22. Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D & Zhou Y (2012b). Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Exp Physiol 97, 277-289.
23. Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D & Zhou Y (2012c). Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries. Am J Physiol Renal Physiol 302, F1133-F1140.
24. Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D & Zhou Y (2013). Effect of celecoxib on cyclooxygenase-1-mediated prostacyclin synthesis and endothelium-dependent contraction in mouse arteries. Eur J Pharmacol 698, 354-361.
25. Mitchell JA, Lucas R, Vojnovic I, Hasan K, Pepper JR & Warner TD (2006). Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events. FASEB J 20, 2468-2475.
26. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA & Smithies O (1995). Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473-482.
27. Needleman P, Moncada S, Bunting S, Vane JR, Hamberg M & Samuelsson B (1976). Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature 261, 558-560.
28. Niwa K, Haensel C, Ross ME & Iadecola C (2001). Cyclooxygenase-1 participates in selected vasodilator responses of the cerebral circulation. Circ Res 88, 600-608.
29. Okon EB, Golbabaie A & van Breemen C (2002). In the presence of L-NAME SERCA blockade induces endothelium-dependent contraction of mouse aorta through activation of smooth muscle prostaglandin H2/thromboxane A2 receptors. Br J Pharmacol 137, 545-553.
30. Quilley J & Chen YJ (2003). Role of COX-2 in the enhanced vasoconstrictor effect of arachidonic acid in the diabetic rat kidney. Hypertension 42, 837-843.
31. Rapoport RM & Williams SP (1996). Role of prostaglandins in acetylcholine-induced contraction of aorta from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension 28, 64-75.
32. Rouzer CA & Marnett LJ (2009). Cyclooxygenases: structural and functional insights. J Lipid Res 50(Suppl), S29-S34.
33. Ruan CH, So SP & Ruan KH (2012). Inducible COX-2 dominates over COX-1 in prostacyclin biosynthesis: mechanisms of COX-2 inhibitor risk to heart disease. Life Sci 88, 24-30.
34. 2. Br J Pharmacol 115, 1215-1220.
35. Smith WL, DeWitt DL & Garavito RM (2000). Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69, 145-182.
36. Smith WL & Langenbach R (2001). Why there are two cyclooxygenase isozymes. J Clin Invest 107, 1491-1495.
37. Sun D, Liu H, Yan C, Jacobson A, Ojaimi C, Huang A & Kaley G (2006). COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice. Am J Physiol Heart Circ Physiol 291, H1429-H1435.
38. -/- knockout mice. J Cardiovasc Pharmacol 46, 761-765.
39. Traupe T, Lang M, Goettsch W, Munter K, Morawietz H, Vetter W & Barton M (2002). Obesity increases prostanoid-mediated vasoconstriction and vascular thromboxane receptor gene expression. J Hypertens 20, 2239-2245.
40. Vanhoutte PM (2011). Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension 57, 526-531.
41. 2α mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res 104, 228-235.
42. 2 and prostacyclin. Br J Pharmacol 154, 1225-1235.
43. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA & Zweier JL (2005). Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 289, H1027-H1032.